Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 223

The DOI matches its Crossref record.

Thrombolytic Therapy of Pulmonary Embolism

Open access
Arcasoy, Selim M., Kreit, John W. · 1999 · Chest

Abstract

Pulmonary embolism (PE) is a common disorder that is accompanied by significant morbidity and mortality. Although anticoagulation is the standard treatment for PE, thrombolytic therapy, with its ability to produce rapid clot lysis, has long been considered an attractive alternative. Although many studies have been performed over the past three decades, however, the indications for the use of thrombolytic agents in patients with PE remain controversial. In this article, we review the medical literature and provide evidence-based guidelines for the use of thrombolytic therapy. We will also discuss the practical aspects of PE thrombolysis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1378/chest.115.6.1695

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 102

  1. Coon, 1959, Deep venous thrombosis and pulmonary embolism: prediction, prevention and treatment, Am J Cardiol, 4, 611, 10.1016/0002-9149(59)90145-6 · doi:10.1016/0002-9149(59)90145-6
  2. Dalen, 1975, Natural history of pulmonary embolism, Prog Cardiovasc Dis, 17, 259, 10.1016/S0033-0620(75)80017-X · DOI · Paper page
  3. Bell, 1982, Current status of pulmonary thromboembolic disease: pathophysiology, diagnosis, prevention and treatment, Am Heart J, 103, 239, 10.1016/0002-8703(82)90498-7 · doi:10.1016/0002-8703(82)90498-7
  4. Lilienfeld, 1990, Mortality from pulmonary embolism in the United States: 1962 to 1984, Chest, 98, 1067, 10.1378/chest.98.5.1067 · doi:10.1378/chest.98.5.1067
  5. Morrell, 1968, The post-mortem incidence of pulmonary embolism in a hospital population, Br J Surg, 55, 347, 10.1002/bjs.1800550506 · doi:10.1002/bjs.1800550506
  6. Uhland, 1964, Pulmonary embolism: a commonly missed clinical entity, Dis Chest, 45, 533, 10.1378/chest.45.5.533 · doi:10.1378/chest.45.5.533
  7. Goldhaber, 1982, Factors associated with correct antemortem diagnosis of major pulmonary embolism, Am J Med, 73, 822, 10.1016/0002-9343(82)90764-1 · DOI · Paper page
  8. Anderson, 1991, A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study, Arch Intern Med, 151, 933, 10.1001/archinte.1991.00400050081016 · DOI · Paper page
  9. Barritt, 1960, Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial, Lancet, 1, 1309, 10.1016/S0140-6736(60)92299-6 · DOI · Paper page
  10. Sasahara, 1983, Pulmonary thromboembolism: diagnosis and treatment, JAMA, 249, 2945, 10.1001/jama.1983.03330450075032 · doi:10.1001/jama.1983.03330450075032
  11. Hermann, 1961, Pulmonary embolism: a clinical and pathologic study with emphasis on the effect of prophylactic therapy with anticoagulants, Am J Surg, 102, 19, 10.1016/0002-9610(61)90680-8 · doi:10.1016/0002-9610(61)90680-8
  12. 1970, Urokinase Pulmonary Embolism Trial: phase 1 results—a cooperative study, JAMA, 214, 2163, 10.1001/jama.1970.03180120035007 · DOI · Paper page
  13. 1974, Urokinase-Streptokinase Embolism Trial: phase 2 results—a cooperative study, JAMA, 229, 1606, 10.1001/jama.1974.03230500024021 · DOI · Paper page
  14. Carson, 1992, The clinical course of pulmonary embolism, N Engl J Med, 326, 1240, 10.1056/NEJM199205073261902 · DOI · Paper page
  15. Ferrari, 1997, Clinical epidemiology of venous thromboembolic disease: results of a French multicentre registry, Eur Heart J, 18, 685, 10.1093/oxfordjournals.eurheartj.a015316 · doi:10.1093/oxfordjournals.eurheartj.a015316
  16. Lund, 1987, Pulmonary embolism: long-term follow-up after treatment with full-dose heparin, streptokinase or embolectomy, Acta Med Scand, 221, 61, 10.1111/j.0954-6820.1987.tb01246.x · doi:10.1111/j.0954-6820.1987.tb01246.x
  17. Alpert, 1976, Mortality in patients treated for pulmonary embolism, JAMA, 236, 1477, 10.1001/jama.1976.03270140029017 · DOI · Paper page
  18. Dalla-Volta, 1992, PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism: Plasminogen Activator Italian Multicenter Study 2, J Am Coll Cardiol, 20, 520, 10.1016/0735-1097(92)90002-5 · DOI · Paper page
  19. Goldhaber, 1993, Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion, Lancet, 341, 507, 10.1016/0140-6736(93)90274-K · DOI · Paper page
  20. Kasper, 1997, Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry, J Am Coll Cardiol, 30, 1165, 10.1016/S0735-1097(97)00319-7 · DOI · Paper page
  21. Konstantinides, 1997, Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry, Circulation, 96, 882, 10.1161/01.CIR.96.3.882 · DOI · Paper page
  22. Monreal, 1989, Recurrent pulmonary embolism: a prospective study, Chest, 95, 976, 10.1378/chest.95.5.976 · doi:10.1378/chest.95.5.976
  23. Paraskos, 1973, Late prognosis of acute pulmonary embolism, N Engl J Med, 289, 55, 10.1056/NEJM197307122890201 · DOI · Paper page
  24. Phear, 1960, Pulmonary embolism: a study of late prognosis, Lancet, 2, 832, 10.1016/S0140-6736(60)91903-6 · doi:10.1016/s0140-6736(60)91903-6
  25. van Beek, 1997, The clinical course of patients with suspected pulmonary embolism, Arch Intern Med, 157, 2593, 10.1001/archinte.1997.00440430075009 · doi:10.1001/archinte.1997.00440430075009
  26. Wheeler, 1988, Physician practices in the treatment of pulmonary embolism and deep vein thrombosis, Arch Intern Med, 148, 1321, 10.1001/archinte.1988.00380060085018 · DOI
  27. Walker, 1970, Resolution of pulmonary embolism, BMJ, 4, 135, 10.1136/bmj.4.5728.135 · doi:10.1136/bmj.4.5728.135
  28. Goldhaber, 1995, The international cooperative pulmonary embolism registry, Chest, 108, 302, 10.1378/chest.108.2.302 · doi:10.1378/chest.108.2.302
  29. Girard, 1987, Recurrence of pulmonary embolism during anticoagulant treatment: a prospective study, Thorax, 42, 481, 10.1136/thx.42.7.481 · DOI
  30. Dalen, 1969, Resolution rate of acute pulmonary embolism in man, N Engl J Med, 280, 1194, 10.1056/NEJM196905292802202 · doi:10.1056/nejm196905292802202
  31. Fred, 1966, Rapid resolution of pulmonary thromboemboli in man: angiographic study, JAMA, 196, 1137, 10.1001/jama.1966.03100260075021 · doi:10.1001/jama.1966.03100260075021
  32. Tow, 1967, Recovery of pulmonary arterial blood flow in patients with pulmonary embolism, N Engl J Med, 276, 1053, 10.1056/NEJM196705112761902 · doi:10.1056/nejm196705112761902
  33. Cook, 1995, Clinical recommendations using levels of evidence for antithrombotic agents, Chest, 108, 227S, 10.1378/chest.108.4_Supplement.227S · DOI · Paper page
  34. Sharma, 1982, Thrombolytic therapy, N Engl J Med, 306, 1268, 10.1056/NEJM198205273062105 · doi:10.1056/nejm198205273062105
  35. Marder, 1988, Thrombolytic therapy: current status, N Engl J Med, 318, 1512, 10.1056/NEJM198806093182306 · DOI · Paper page
  36. Loscalzo, 1990, An overview of thrombolytic agents, Chest, 97, 117S, 10.1378/chest.97.4_Supplement.117S · DOI
  37. Hyers, 1995, Antithrombotic therapy for venous thromboembolic disease, Chest, 108, 335S, 10.1378/chest.108.4_Supplement.335S · DOI
  38. Gulba, 1996, Thrombolytic agents: an overview, Ann Hematol, 73, S9
  39. Agnelli, 1992, Bolus thrombolysis in venous thromboembolism, Chest, 101, 172S, 10.1378/chest.101.4_Supplement.172S · DOI
  40. Agnelli, 1997, Rationale for the bolus administration of fibrin-specific thrombolytic agents, Fibrinolysis & Proteolysis, 11, 23, 10.1016/S0268-9499(97)80066-5 · doi:10.1016/s0268-9499(97)80066-5
  41. Agnelli, 1990, Rationale for bolus t-PA therapy to improve efficacy and safety, Chest, 97, 161S, 10.1378/chest.97.4_Supplement.161S · doi:10.1378/chest.97.4_supplement.161s
  42. Agnelli, 1997, Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism, Blood Coagul Fibrinolysis, 8, 216, 10.1097/00001721-199706000-00002 · doi:10.1097/00001721-199706000-00002
  43. Goldhaber, 1986, Acute pulmonary embolism treated with tissue plasminogen activator, Lancet, 2, 886, 10.1016/S0140-6736(86)90411-3 · doi:10.1016/s0140-6736(86)90411-3
  44. Goldhaber, 1988, Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism, Lancet, 2, 293, 10.1016/S0140-6736(88)92354-9 · DOI · Paper page
  45. Browse, 1964, Streptokinase and pulmonary embolism, Lancet, 11, 1039, 10.1016/S0140-6736(64)90991-2 · doi:10.1016/s0140-6736(64)90991-2
  46. Genton, 1968, Urokinase therapy in pulmonary thromboembolism, Am Heart J, 76, 628, 10.1016/0002-8703(68)90161-0 · doi:10.1016/0002-8703(68)90161-0
  47. Miller, 1969, Treatment of pulmonary embolism with streptokinase: a preliminary report, BMJ, 1, 812, 10.1136/bmj.1.5647.812 · doi:10.1136/bmj.1.5647.812
  48. Miller, 1971, Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism, BMJ, 2, 681, 10.1136/bmj.2.5763.681 · DOI · Paper page
  49. Sautter, 1967, Urokinase for the treatment of acute pulmonary thromboembolism, JAMA, 202, 215, 10.1001/jama.1967.03130160089019 · doi:10.1001/jama.1967.03130160089019
  50. Sasahara, 1967, Urokinase therapy in clinical pulmonary embolism: a new thrombolytic agent, N Engl J Med, 277, 1168, 10.1056/NEJM196711302772203 · doi:10.1056/nejm196711302772203
  51. Tow, 1967, Urokinase in pulmonary embolism, N Engl J Med, 277, 1161, 10.1056/NEJM196711302772202 · DOI
  52. Dickie, 1974, Hemodynamic effects of bolus infusion of urokinase in pulmonary thromboembolism, Am Rev Respir Dis, 109, 48
  53. Hirsh, 1968, Streptokinase therapy in acute major pulmonary embolism: effectiveness and problems, BMJ, 4, 729, 10.1136/bmj.4.5633.729 · doi:10.1136/bmj.4.5633.729
  54. Sharma, 1980, Effect of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolism, N Engl J Med, 303, 842, 10.1056/NEJM198010093031502 · DOI · Paper page
  55. Tibbutt, 1974, Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonary embolism, BMJ, 1, 343, 10.1136/bmj.1.5904.343 · DOI · Paper page
  56. Ly, 1978, A controlled trial of streptokinase and heparin in the treatment of major pulmonary embolism, Acta Med Scand, 203, 465, 10.1111/j.0954-6820.1978.tb14909.x · DOI · Paper page
  57. Marini, 1988, Fibrinolytic effects of urokinase and heparin in acute pulmonary embolism: a randomized clinical trial, Respiration, 54, 162, 10.1159/000195517 · DOI
  58. PIOPED Investigators, 1990, Tissue plasminogen activator for the treatment of acute pulmonary embolism: a collaborative study by the PIOPED Investigators, Chest, 97, 528, 10.1378/chest.97.3.528 · DOI · Paper page
  59. Levine, 1990, A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism, Chest, 98, 1473, 10.1378/chest.98.6.1473 · DOI · Paper page
  60. Jerjes-Sanchez, 1995, Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial, J Thromb Thrombolysis, 2, 227, 10.1007/BF01062714 · DOI · Paper page
  61. Sharma, 1990, Long-term hemodynamic benefit of thrombolytic therapy in pulmonary embolic disease [abstract], J Am Coll Cardiol, 15, 65A, 10.1016/0735-1097(90)91976-2 · doi:10.1016/0735-1097(90)91976-2
  62. Meyer, 1992, Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial, J Am Coll Cardiol, 19, 239, 10.1016/0735-1097(92)90472-Y · DOI · Paper page
  63. Goldhaber, 1992, Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial, J Am Coll Cardiol, 20, 24, 10.1016/0735-1097(92)90132-7 · DOI · Paper page
  64. Meneveau, 1997, Streptokinase vs alteplase in massive pulmonary embolism: a randomized trial assessing right heart hemodynamics and pulmonary vascular obstruction, Eur Heart J, 18, 1141, 10.1093/oxfordjournals.eurheartj.a015410 · DOI
  65. Meneveau, 1998, Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up, J Am Coll Cardiol, 31, 1057, 10.1016/S0735-1097(98)00068-0 · DOI · Paper page
  66. Tapson, 1992, Rapid thrombolysis of massive pulmonary emboli without systemic fibrinogenolysis: intraembolic infusion of thrombolytic therapy [abstract], Am Rev Respir Dis, 145, A719
  67. Schwarz, 1985, Sustained improvement of pulmonary hemodynamics in patients at rest and during exercise after thrombolytic treatment of massive pulmonary embolism, Circulation, 71, 117, 10.1161/01.CIR.71.1.117 · doi:10.1161/01.cir.71.1.117
  68. Petitpretz, 1984, Effects of a single bolus of urokinase in patients with life-threatening pulmonary emboli: a descriptive trial, Circulation, 70, 861, 10.1161/01.CIR.70.5.861 · doi:10.1161/01.cir.70.5.861
  69. Vujic, 1983, Massive pulmonary embolism: treatment with full heparinization and topical low-dose streptokinase, Radiology, 148, 671, 10.1148/radiology.148.3.6878682 · doi:10.1148/radiology.148.3.6878682
  70. Leeper, 1988, Treatment of massive acute pulmonary embolism: the use of low doses of intrapulmonary arterial streptokinase combined with full doses of systemic heparin, Chest, 93, 234, 10.1378/chest.93.2.234 · doi:10.1378/chest.93.2.234
  71. Gallus, 1975, Thrombolysis with a combination of small doses of streptokinase and full doses of heparin, Semin Thromb & Hemost, 2, 14, 10.1055/s-0028-1086112 · doi:10.1055/s-0028-1086112
  72. Edwards, 1973, Low-dose urokinase in major pulmonary embolism, Lancet, 2, 409, 10.1016/S0140-6736(73)92273-3 · doi:10.1016/s0140-6736(73)92273-3
  73. Barberena, 1983, Intraarterial infusion of urokinase in the treatment of acute pulmonary thromboembolism: preliminary observations, AJR Am J Roentgenol, 140, 883, 10.2214/ajr.140.5.883 · doi:10.2214/ajr.140.5.883
  74. Verstraete, 1988, Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism, Circulation, 77, 353, 10.1161/01.CIR.77.2.353 · DOI · Paper page
  75. Fava, 1997, Mechanical fragmentation and pharmacologic thrombolysis in massive pulmonary embolism, J Vasc Interv Radiol, 8, 261, 10.1016/S1051-0443(97)70552-9 · DOI
  76. Stern, 1988, Urokinase versus tissue plasminogen activator in pulmonary embolism, Lancet, 2, 691
  77. Diehl, 1992, Effectiveness and safety of bolus administration of alteplase in massive pulmonary embolism, Am J Cardiol, 70, 1477, 10.1016/0002-9149(92)90302-F · doi:10.1016/0002-9149(92)90302-f
  78. Goldhaber, 1994, Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis: an international multicenter randomized trial, Chest, 106, 718, 10.1378/chest.106.3.718 · DOI · Paper page
  79. Goldhaber, 1994, Two trials of reduced bolus alteplase in the treatment of pulmonary embolism: an overview, Chest, 106, 725, 10.1378/chest.106.3.725 · doi:10.1378/chest.106.3.725
  80. Sors, 1994, Hemodynamic effects of bolus vs 2-h infusion of alteplase in acute massive pulmonary embolism: a randomized controlled multicenter trial, Chest, 106, 712, 10.1378/chest.106.3.712 · DOI · Paper page
  81. Palla, 1997, Resolution of pulmonary embolism: effect of therapy and putative age of emboli, Respiration, 64, 50, 10.1159/000196642 · doi:10.1159/000196642
  82. Daniels, 1997, Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism, Am J Cardiol, 80, 184, 10.1016/S0002-9149(97)00315-9 · DOI · Paper page
  83. Levine, 1995, Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism, Chest, 108, 291S, 10.1378/chest.108.4_Supplement.291S · DOI
  84. Kanter, 1997, Thrombolytic therapy for pulmonary embolism: frequency of intracranial hemorrhage and associated risk factors, Chest, 111, 1241, 10.1378/chest.111.5.1241 · DOI · Paper page
  85. Lualdi, 1995, Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implications, Am Heart J, 130, 1276, 10.1016/0002-8703(95)90155-8 · DOI · Paper page
  86. Goldhaber, 1997, Pulmonary embolism thrombolysis: broadening the paradigm for its administration, Circulation, 96, 716, 10.1161/01.CIR.96.3.716 · doi:10.1161/01.cir.96.3.716
  87. Goldhaber, 1995, Thrombolytic therapy in venous thromboembolism: clinical trials and current indications, Clin Chest Med, 16, 307, 10.1016/S0272-5231(21)01094-7 · DOI
  88. 1996, Opinions regarding the diagnosis and management of venous thromboembolic disease: ACCP Consensus Committee on Pulmonary Embolism, Chest, 109, 233, 10.1378/chest.109.1.233 · doi:10.1378/chest.109.1.233
  89. Goodman, 1995, Detection of pulmonary embolism in patients with unresolved clinical and scintigraphic diagnosis: helical CT versus angiography, AJR Am J Roentgenol, 164, 1369, 10.2214/ajr.164.6.7754875 · doi:10.2214/ajr.164.6.7754875
  90. Remy-Jardin, 1996, Diagnosis of pulmonary embolism with spiral CT: comparison with pulmonary angiography and scintigraphy, Radiology, 200, 699, 10.1148/radiology.200.3.8756918 · doi:10.1148/radiology.200.3.8756918
  91. van Rossum, 1996, Pulmonary embolism: validation of spiral CT angiography in 149 patients, Radiology, 201, 467, 10.1148/radiology.201.2.8888242 · doi:10.1148/radiology.201.2.8888242
  92. van Rossum, 1996, Role of spiral volumetric computed tomographic scanning in the assessment of patients with clinical suspicion of pulmonary embolism and an abnormal ventilation/perfusion scan, Thorax, 51, 23, 10.1136/thx.51.1.23 · doi:10.1136/thx.51.1.23
  93. Gefter, 1995, Pulmonary thromboembolism: recent developments in diagnosis with CT and MR imaging, Radiology, 197, 561, 10.1148/radiology.197.3.7480717 · doi:10.1148/radiology.197.3.7480717
  94. Blum, 1994, Spiral-computed tomography versus pulmonary angiography in the diagnosis of acute massive pulmonary embolism, Am J Cardiol, 74, 96, 10.1016/0002-9149(94)90502-9 · doi:10.1016/0002-9149(94)90502-9
  95. Kasper, 1986, Echocardiographic findings in patients with proved pulmonary embolism, Am Heart J, 112, 1284, 10.1016/0002-8703(86)90361-3 · doi:10.1016/0002-8703(86)90361-3
  96. Jardin, 1987, Quantitative two-dimensional echocardiography in massive pulmonary embolism: emphasis on ventricular interdependence and leftward septal displacement, J Am Coll Cardiol, 10, 1201, 10.1016/S0735-1097(87)80119-5 · DOI · Paper page
  97. Come, 1987, Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activator, J Am Coll Cardiol, 10, 971, 10.1016/S0735-1097(87)80333-9 · doi:10.1016/s0735-1097(87)80333-9
  98. Come, 1992, Echocardiographic evaluation of pulmonary embolism and its response to therapeutic interventions, Chest, 101, 151S, 10.1378/chest.101.4_Supplement.151S · doi:10.1378/chest.101.4_supplement.151s
  99. McConnell, 1996, Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism, Am J Cardiol, 78, 469, 10.1016/S0002-9149(96)00339-6 · DOI · Paper page
  100. 1980, Thrombolytic therapy in thrombosis: a National Institutes of Health consensus development conference, Ann Intern Med, 93, 141, 10.7326/0003-4819-93-1-141 · DOI · Paper page
  101. Goldhaber, 1995, Contemporary pulmonary embolism thrombolysis, Chest, 107, 45S, 10.1378/chest.107.1_Supplement.45S · DOI
  102. Goldhaber, 1991, Recent advances in the diagnosis and lytic therapy of pulmonary embolism, Chest, 99, 173S, 10.1378/chest.99.4.173S · doi:10.1378/chest.99.4.173s

Cited by

See all 223

Metadata

Authors
Arcasoy, S. M., & Kreit, J. W.
Venue
Chest
Publisher
Elsevier BV
Published
1999-06
Volume
115
Issue
6
Pages
1695-1707
ISSN
0012-3692 (ISSN-L)
OpenAlex
W2103326534
Cited by
223
References
0
FWCI
13.16
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Thrombolytic Therapy of Pulmonary Embolism. https://app.cochat.ai/papers/10.1378/chest.115.6.1695
The paper
Arcasoy, S. M., & Kreit, J. W. (1999). Thrombolytic Therapy of Pulmonary Embolism. Chest. https://doi.org/10.1378/chest.115.6.1695

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.